Study on transcriptional regulation in CD40 signaling.
Study on transcriptional regulation in CD40 signaling.
批准号:
12670295
负责人:
TSUBATA Takeshi
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CD40 signaling plays an essential role in immune responses. CD40 signaling activates various signaling molecules such as the transcription factor NF-kB. However, it is not yet elucidated how these signaling molecules regulate the target genes. It is also not yet clear how the products of the target genes are involved in immune responses. Previously, we demonstrated that CD40 signaling reduces the mRNA level of the cell cycle inhibitor kip1. First, we addressed the molecular mechanisms for the repression of kip1 by CD40 signaling. We assessed the promoter activity of the kip1 gene by luciferace assay using 3T3 cells, and demonstrated that NF-kB repress the kip1 promoter. Further the region containing -581 to -348 in the kip1 promoter carry two NF-kB recognition sequences and the promoter activity in this region is suppressed by NF-kB. This suggests that this region may play a role in CD40-mediated suppression of the kip1 level. However, NF-kB-mediated suppression still occurs even if the NF-kB site is mutated. Thus, how NF-kB represses the promoter activity in this region is still unclear. Next, we assessed the role of kip1 repression in CD40-mediated B cell proliferation and survival. Since p27kip1 inhibits CDKs essential fur cell cycle progression, kip1 repression may play a role in B cell proliferation induced by CD40 signaling. CD40 signaling induces survival of the B cells including the B cell line WEHI-231 by abrogating antigen receptor-mediated apoptosis. When we expressed kip1 in WEHI-231 cells using a retrovirus vector, survival of antigen receptor-ligated WEHI-231 cells is partially impaired. This indicates that kip1 suppression is required for fully restore antigen receptor-induced apoptosis by CD40 signaling. Taken together kip1 repression appears to involve NF-kB and play a role in proliferation and survival of B cells.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tsubata T: "Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas(CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice"Int. Immunol.. 12. 517-526 (2000)
Tsubata T:“抗原受体连接诱导的快速 B 细胞凋亡不需要 Fas(CD95/APO-1)、接头蛋白 FADD/MORT1 或 CrmA 敏感的半胱天冬酶,但 MRL- / 和 MRL-lpr/lpr 均存在缺陷
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tsubata T: "B cell tolerance and autoimmunity"Rev.Immunogenet.. 2. 18-25 (2000)
Tsubata T:“B 细胞耐受性和自身免疫”Rev.Immunogenet.. 2. 18-25 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tsubata T: "Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1),the adapter protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice"Int.Immunol.. 12. 517-526 (2000)
Tsubata T:“抗原受体连接诱导的快速 B 细胞凋亡不需要 Fas (CD95/APO-1)、接头蛋白 FADD/MORT1 或 CrmA 敏感的半胱天冬酶,但 MRL- / 和 MRL-lpr/lpr 都有缺陷
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Higuchi T: "Cutting Edge : Ectopic expression of CD40 llgand on B calls induces lupus-likeautolmmune disease"J. Immunol. 168. 9-12 (2002)
Higuchi T:“前沿:B 细胞上 CD40 配体的异位表达诱导狼疮样自身免疫性疾病”J.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tsubata T: "Molecular mechanisms for apoptosis induced by siganling through the B cell antigen receptor"Int. Rev. Immunol.. Vol.20 No.6. 791-803 (2001)
Tsubata T:“信号通过 B 细胞抗原受体诱导细胞凋亡的分子机制”Int。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 23 条
Studies on Siglecs expressed on B lymphocytes and their glycan ligands
-
批准号:26293062
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.32万
-
财政年份:2014
-
负责人:TSUBATA Takeshi
-
依托单位:
Carbohydrate recognition of B lymphocyte lectins and their function
-
批准号:23390063
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.32万
-
财政年份:2011
-
负责人:TSUBATA Takeshi
-
依托单位:
Immunogenetic analysis of the resistance to infectious diseases
-
批准号:18406019
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.89万
-
财政年份:2006
-
负责人:TSUBATA Takeshi
-
依托单位:
Roles of membrane-bound lectins in the regulation of immune cells.
-
批准号:15390158
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.66万
-
财政年份:2003
-
负责人:TSUBATA Takeshi
-
依托单位:
Regulation of cell death by cell cycling
-
批准号:13043013
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$67.97万
-
财政年份:2001
-
负责人:TSUBATA Takeshi
-
依托单位:
Regulatory mechanisms for self-reactive B cells with somatic mutations in the immunoglobulin genes
-
批准号:09470092
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:1997
-
负责人:TSUBATA Takeshi
-
依托单位:
Study of CDK inhibitors in B cell immune response
-
批准号:09044292
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.65万
-
财政年份:1997
-
负责人:TSUBATA Takeshi
-
依托单位:
Establishment of a spontaneous single gene model for Sjogren's syndrome
-
批准号:07557032
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$1.28万
-
财政年份:1995
-
负责人:TSUBATA Takeshi
-
依托单位:
Control mechanisms for B cell apoptosis and differentiation
-
批准号:06044130
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$9.34万
-
财政年份:1994
-
负责人:TSUBATA Takeshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
转录因子BCL6抑制ICOSL表达优化生发中心反应的机制研究
-
批准号:82371745
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张文倩
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位:
KLF5诱导小鼠始发态多能性干细胞向滋养层干细胞转变的作用与机制研究
-
批准号:32100596
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:黄颖华
-
依托单位:
锌指蛋白ZBTB17调控成纤维细胞衰老的机制研究
-
批准号:32000509
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:马兴杰
-
依托单位:
细胞衰老抑制直接重编程及心肌再生修复的分子机理研究
-
批准号:92068107
-
项目类别:重大研究计划
-
资助金额:79.0万元
-
批准年份:2020
-
负责人:王丽
-
依托单位:
转录因子SALL4通过影响pre-mRNA可变剪接调控非Yamanaka因子体细胞重编程的机制研究
-
批准号:32000502
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王波
-
依托单位:
DNA糖苷酶OGG1调节PARP1介导的EB病毒潜伏蛋白表达的机制研究
-
批准号:32000546
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:郝文静
-
依托单位: